The enactment of HB 5351 is projected to have significant implications for health insurance practices in Rhode Island. By requiring coverage for infertility treatment, the bill seeks to align insurance policies with the medical needs of many couples facing difficulties in conceiving. It emphasizes the importance of providing accessible healthcare solutions, thereby potentially increasing the usage of infertility treatments among residents. However, the bill allows a lifetime cap of $100,000 for treatment, which might still present challenges for those requiring multiple procedures or advanced treatments.
Summary
House Bill 5351, also referred to as the Infertility Coverage Act, mandates that all health insurance policies delivering pregnancy-related benefits in Rhode Island must include coverage for the diagnosis and treatment of infertility for women aged 25 to 42. This act specifically addresses costs associated with medically necessary treatments, including preimplantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF). Such extensive coverage aims to remove financial barriers for couples experiencing infertility, therefore promoting reproductive health and family planning options for women within the specified age range.
Contention
The bill could face scrutiny and contention surrounding the financial implications for insurance providers and whether the lifetime cap is sufficient for comprehensive infertility treatment. Proponents argue that such legislation is necessary for modern healthcare equity and will help families achieve their reproductive goals. Critics might express concerns about the increased burden on insurance companies and potential rising premiums, alongside debates about mandating coverage for specific medical conditions and the influence of private insurance market adjustments.
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of diagnosing and treating infertility, for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with IVF.
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates all insurance plans provide insurance coverage for diagnosing and treating infertility for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of testing and treating infertility, including preimplantation genetic testing (PGT), in conjunction with in vitro fertilization (IVF).
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of diagnosing and treating infertility, for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with IVF.
Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of testing and treating infertility, including preimplantation genetic testing (PGT), in conjunction with in vitro fertilization (IVF).
Mandates all insurance plans provide insurance coverage for diagnosing and treating infertility for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).